Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 19 studies | 45% ± 23% | |
peripheral blood | 15 studies | 45% ± 29% | |
brain | 14 studies | 37% ± 13% | |
intestine | 11 studies | 47% ± 26% | |
kidney | 8 studies | 34% ± 14% | |
eye | 5 studies | 52% ± 23% | |
uterus | 5 studies | 68% ± 29% | |
liver | 5 studies | 47% ± 13% | |
pancreas | 4 studies | 49% ± 18% | |
placenta | 4 studies | 59% ± 28% | |
lymph node | 4 studies | 48% ± 21% | |
breast | 4 studies | 65% ± 21% | |
bone marrow | 3 studies | 63% ± 28% | |
prostate | 3 studies | 45% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 14451.11 | 258 / 258 | 100% | 527.71 | 230 / 230 |
ovary | 100% | 32627.47 | 180 / 180 | 100% | 674.70 | 430 / 430 |
uterus | 100% | 16842.45 | 170 / 170 | 100% | 334.88 | 459 / 459 |
intestine | 100% | 14065.53 | 965 / 966 | 100% | 331.26 | 526 / 527 |
brain | 99% | 11915.26 | 2627 / 2642 | 100% | 263.32 | 705 / 705 |
prostate | 100% | 13824.13 | 244 / 245 | 100% | 419.07 | 500 / 502 |
stomach | 99% | 12177.17 | 357 / 359 | 99% | 374.31 | 284 / 286 |
thymus | 99% | 13903.33 | 645 / 653 | 100% | 428.86 | 603 / 605 |
esophagus | 98% | 10580.30 | 1420 / 1445 | 100% | 414.75 | 183 / 183 |
breast | 100% | 21507.51 | 459 / 459 | 98% | 286.72 | 1097 / 1118 |
bladder | 100% | 10599.43 | 21 / 21 | 98% | 275.50 | 492 / 504 |
lung | 99% | 19043.42 | 575 / 578 | 97% | 227.52 | 1123 / 1155 |
kidney | 98% | 11361.97 | 87 / 89 | 98% | 237.53 | 886 / 901 |
skin | 98% | 13719.96 | 1765 / 1809 | 99% | 203.23 | 465 / 472 |
pancreas | 97% | 7908.24 | 318 / 328 | 98% | 308.00 | 174 / 178 |
liver | 92% | 9002.39 | 207 / 226 | 100% | 260.65 | 404 / 406 |
eye | 0% | 0 | 0 / 0 | 100% | 220.59 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 237.34 | 29 / 29 |
tonsil | 0% | 0 | 0 / 0 | 100% | 213.13 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 421.11 | 1 / 1 |
blood vessel | 100% | 18422.70 | 1331 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 18747.26 | 1200 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 8589.11 | 240 / 241 | 0% | 0 | 0 / 0 |
heart | 97% | 9891.53 | 833 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 12358.14 | 889 / 929 | 0% | 0 | 0 / 0 |
muscle | 62% | 2914.92 | 500 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045669 | Biological process | positive regulation of osteoblast differentiation |
GO_0071277 | Biological process | cellular response to calcium ion |
GO_0010467 | Biological process | gene expression |
GO_0002076 | Biological process | osteoblast development |
GO_0042127 | Biological process | regulation of cell population proliferation |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0035976 | Cellular component | transcription factor AP-1 complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0017053 | Cellular component | transcription repressor complex |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0000785 | Cellular component | chromatin |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0008134 | Molecular function | transcription factor binding |
GO_0019899 | Molecular function | enzyme binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0001221 | Molecular function | transcription coregulator binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | JUND |
Protein name | Transcription factor JunD (Transcription factor AP-1 subunit JunD) |
Synonyms | |
Description | FUNCTION: Transcription factor binding AP-1 sites . Heterodimerizes with proteins of the FOS family to form an AP-1 transcription factor complex, thereby enhancing their DNA binding activity to an AP-1 consensus sequence 3'-TGA[GC]TCA-5' and enhancing their transcriptional activity . . |
Accessions | P17535 ENST00000600972.1 U3KPR5 ENST00000252818.5 |